SCHEMBL6060609

SCHEMBL6060609

CC(C)CC1(CC(C)C)c2ccccc2-c2ccccc21

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ APEX1 P27695 1/20 0.42
▸ ELANE P08246 1/20 0.41
▸ PDK2 Q15119 5/20 0.40
▸ KCNQ2 O43526 2/20 0.35
▸ CYP1A2 P05177 1/20 0.35
▸ CYP3A4 P08684 1/20 0.35
▸ CYP2C9 P11712 1/20 0.35
▸ ALOX15 P16050 1/20 0.35
▸ TSHR P16473 1/20 0.35
▸ RAB9A P51151 1/20 0.35
▸ THRB P10828 1/20 0.34
▸ TDP1 Q9NUW8 1/20 0.34
▸ ALDH1A1 P00352 2/20 0.34
▸ KDM4E B2RXH2 2/20 0.34
▸ S100A4 P26447 1/20 0.33
▸ MEN1 O00255 1/20 0.33
▸ LMNA P02545 1/20 0.33
▸ MAPT P10636 1/20 0.33
▸ OPRK1 P41145 1/20 0.33
▸ KMT2A Q03164 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14174134 0.83 PDK2 (0.45) APEX1ELANEPDK2CYP3A4TSHR
SCHEMBL19704581 0.82 PDK2 (0.39) APEX1ELANEPDK2KCNQ2
SCHEMBL19718513 0.82 PDK2 (0.36) APEX1ELANEPDK2
SCHEMBL17358869 0.79 PDK2 (0.40) APEX1ELANEPDK2CYP1A2CYP3A4
SCHEMBL24314140 0.78 PDK2 (0.38) APEX1ELANEPDK2RAB9ATHRB
SCHEMBL3782236 0.78 APEX1 (0.48) APEX1PDK2KCNQ2CYP1A2CYP3A4
SCHEMBL29441927 0.77 APEX1 (0.51) APEX1PDK2CYP1A2TSHRTHRB
SCHEMBL21219235 0.77 APEX1 (0.51) APEX1PDK2CYP1A2TSHRTHRB
SCHEMBL6705752 0.77 APEX1 (0.36) APEX1PDK2KCNQ2CYP1A2CYP3A4
SCHEMBL15691676 0.75 APEX1 (0.46) APEX1PDK2RAB9ATHRBTDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-103864586-B Bis ether compound and resin combination with fluorene skeleton 新日铁住金化学株式会社 2018-01-09 — — CN disclosed
EP-1298117-B1 Method for preparing bromofluorenes JFE CHEMICAL CORP (JP) 2006-02-15 — — EP disclosed
US-6858764-B2 Method for preparing bromofluorenes JFE CHEMICAL CORPORATION (JP) 2005-02-22 — — US disclosed
US-20030065226-A1 Method for preparing bromofluorenes ADCHEMCO CORPORATION (JP) 2003-04-03 — — US disclosed
EP-1298117-A2 Method for preparing bromofluorenes Adchemco Corporation (JP) 2003-04-02 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030065226-A1 Method for preparing bromofluorenes FLNB, AFF2, BRPF1 APEX1 1019/4885ELANE 1360/4885PDK2 2076/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback